SW
VRTX icon

Simplicity Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Simplicity Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Sell
2,792
-29
-1% -$12.9K 0.05% 346
2026
Q1 		$1.26M Buy
2,821
+403
+17% +$188K 0.07% 251
2025
Q4 		$1.1M Buy
2,418
+405
+20% +$175K 0.07% 260
2025
Q3 		$788K Sell
2,013
-1,022
-34% -$427K 0.05% 345
2025
Q2 		$1.35M Buy
3,035
+1,736
+134% +$800K 0.06% 271
2025
Q1 		$630K Buy
1,299
+581
+81% +$271K 0.05% 307
2024
Q4 		$289K Buy
718
+79
+12% +$36.6K 0.06% 246
2024
Q3 		$297K Sell
639
-26,998
-98% -$13M 0.03% 392
2024
Q2 		$13M Sell
27,637
-850
-3% -$369K 0.29% 68
2024
Q1 		$11.9M Buy
+28,487
New +$12M 0.28% 71

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Simplicity Wealth's VRTX Position: Q2 2026 in Review

Simplicity Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 1% in Q2 2026, selling an estimated $12.9K and leaving 2,792 shares worth $1.39M. The position accounts for 0.05% of the portfolio, ranked #346.

Simplicity Wealth first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $13M in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Simplicity Wealth held 2,792 shares of Vertex Pharmaceuticals worth $1.39M as of Q2 2026.
  • Simplicity Wealth sold 29 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Vertex Pharmaceuticals made up 0.05% of Simplicity Wealth's portfolio in Q2 2026, its #346 holding.
  • Simplicity Wealth first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Simplicity Wealth's Vertex Pharmaceuticals position peaked at $13M in Q2 2024.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.